Efficacy of standard chemotherapy regimens in children and adolescents suffering from respiratory tuberculosis
https://doi.org/10.21292/2075-1230-2020-98-11-45-50
Abstract
The objective of the study: to assess the efficacy of standard chemotherapy regimens in the treatment of children and adolescents suffering from respiratory tuberculosis.
Subjects and methods. 272 children aged 0 to 17 years old with newly diagnosed respiratory tuberculosis were on treatment.
Results. Treatment of children suffering from respiratory tuberculosis with standard chemotherapy regimens made it possible to achieve cure of tuberculosis in 264/272 (97.1%) children and adolescents aged 0-17 years old, 8/272 (2.9%) underwent surgery additionally to chemotherapy.
About the Authors
E. F. LuginovaRussian Federation
Evdokiya F. Luginova - Candidate of Medical Sciences, Deputy Director for Pediatric Patients
93, Petr Alekseev St., Yakutsk, Sakha Republic (Yakutia), 677005
Phone: +7 (4112) 40-38-93
O. I. Gurieva
Russian Federation
Olga I. Gurieva - Candidate of Medical Sciences, Head of Children Tuberculosis Department no. 2
93, Petr Alekseev St., Yakutsk, Sakha Republic (Yakutia), 677005
Phone: +7 (4112) 40-38-41
D. А. Nikolaeva
Russian Federation
Dora A. Nikolaeva - Head of Pediatric Tuberculosis Department no.1
93, Petr Alekseev St., Yakutsk, Sakha Republic (Yakutia), 677005
Phone: +7 (4112) 40-38-36
References
1. Аroyan А.R., Leontiev E.S., Mordyk А.V. Changes to approaches to chemotherapy in the children of tender age over a 30-year period. Tuberculosis and Lung Diseases, 2018, no. 10, pp. 20-22. (In Russ.)
2. Kaminskiy G.D., Kudlay D.А., Panova А.E., Parolina L.E., Peregudova А.B., Pshenichnaya N.Yu., Samoylova А.G., Testov V.V., Tinkova V.V. Taktika vracha pri vyyavlenii, diagnostike i profilaktike sochetannoy infektsii VICH i tuberkulez: prakticheskoe rukovodstvo. [Tactics of the physician in the detection, diagnosis and prevention of TB/HIV coinfection. Practical guide]. I.A. Vasilyeva, eds., Moscow, 2020, 152 p.
3. Kudlay D.А. Biomarkers and immunological tests. Experimental and clinical parallels of latent tuberculosis infection. Tuberculosis and Lung Diseases, 2020, vol. 98, no. 8, pp. 63-74. (In Russ.) http://doi.org/10.21292/2075-1230-2020-98-8-63-74.
4. Lozovskaya M.E. et al. Specific features of the clinical course and chemotherapy of tuberculosis in children exposed to tuberculosis with different drug resistance patterns. Tuberculosis and Lung Diseases, 2019, no. 9, pp. 22-27. (In Russ.)
5. Edict no. 50 by RF MoH as of 13.02.2004 On Introduction of Registration and Reporting Documents for Tuberculosis Monitoring. (In Russ.)
6. Federalnye klinicheskie rekomendatsii po diagnostike i lecheniyu tuberkuleza organov dykhaniya u detey. [Federal recommendations for diagnostics and treatment of respiratory tuberculosis in children]. Moscow, 2014, 27 p.
7. Chiang S.S. et al. Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study. Int. J. Tuberc. Lung Dis., 2017, vol. 21, no. 2, pp. 154-160.
8. Graham S.M., Grzemska M., Gie R.P. The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children. Int. J. Tuberc. Lung Dis., 2015, vol. 19, no. 1, pp. 3-8.
Review
For citations:
Luginova E.F., Gurieva O.I., Nikolaeva D.А. Efficacy of standard chemotherapy regimens in children and adolescents suffering from respiratory tuberculosis. Tuberculosis and Lung Diseases. 2020;98(11):45-50. (In Russ.) https://doi.org/10.21292/2075-1230-2020-98-11-45-50